NCT03188120View on ClinicalTrials.gov

Specific Use-Result of Spiriva Respimat® in Asthmatics

CompletedOBSERVATIONAL
Enrollment

193

Participants

Timeline

Start Date

July 4, 2017

Primary Completion Date

September 22, 2018

Study Completion Date

November 8, 2018

Conditions
Asthma
Interventions
DRUG

Spiriva Respimat

Drug

Trial Locations (1)

1416017

Nippon Boehringer Ingelheim Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY